D. Ross Camidge, MD, PhD

How Medical Physicists Contribute to Optimized Oncologic Outcomes: With D. Ross Camidge, MD, PhD; Alexandra Rink, PhD

March 19th 2025

Drs Camidge and Rink discuss Dr Rink's career in medical physics and the importance of multidisciplinary collaboration to deliver optimal patient care.

Vulnerable Conversations Contribute to Patient Advocacy Efforts to Propel Lung Cancer Research: With D. Ross Camidge, MD, PhD; and Tillman Nechtman, PhD

March 5th 2025

Drs Camidge and Nechtman discuss Dr Nechtman's experience supporting and caring for his wife Laura during her lung cancer diagnosis and treatment.

Dr Camidge on Best Practices for Biomarker Testing in NSCLC

February 24th 2025

D. Ross Camidge, MD, PhD, discusses the benefits of biomarker testing and the potential value of longitudinal testing in non–small cell lung cancer.

How Complementary Roles in Clinic and Industry Illuminate Avenues for Patient-Centered Cancer Care: With D. Ross Camidge, MD, PhD; and Geoff Oxnard, MD

February 19th 2025

Drs. Camidge and Oxnard discuss novel EGFR inhibitors, the role of precision medicine in early cancer detection, and balancing clinical and industry roles.

How Behavioral Science Informs Empathetic and Effective Lung Cancer Prevention Strategies: With D. Ross Camidge, MD, PhD; and Jamie L. Studts, PhD

February 12th 2025

Drs Camidge and Studts discuss Dr Studts' career in behavioral science and the importance of integrating lung cancer screening into primary care.

How Academia and Industry Intersect to Improve Oncology Research and Patient Care: With D. Ross Camidge, MD, PhD; and Tim Eisen, MB BChir, PhD

February 5th 2025

Drs Camidge and Eisen discuss Dr Eisen's dual career in academia and industry, the importance of aligning academic and clinical strengths, and how industry experience can enhance drug development.

How Generalists Are Uniquely Positioned to Administer and Advance Oncology Care: With D. Ross Camidge, MD, PhD; and Rahul Gosain, MD, MBA

January 29th 2025

A Nuanced Understanding of Cellular Biology Advances Neuro-Oncology Practice: With D. Ross Camidge, MD, PhD; and Adrienne A. Boire, MD, PhD

January 22nd 2025

Drs Camidge and Boire discuss Dr Boire's path to becoming a physician-scientist and how cellular biology research can improve outcomes for patients with cancer.

Designing Trials and Fueling Collaboration in Oncology: With D. Ross Camidge, MD, PhD; and Mary Redman, PhD

December 18th 2024

Drs Camidge and Redman discuss Dr Redman's role as a biostatistician at Fred Hutch, outlining her work in designing clinical trials.

Considerations for Taking Oncology Care "to the Ends of the Earth": With D. Ross Camidge, MD, PhD; and Michael Smylie, MBBS, FRCPC

December 5th 2024

Drs Camidge and Smylie discussed Dr Smylie’s experience treating patients who live in the Northwest Territories of Canada.

How the Drive to Connect the Oncology Community Built an Educational Podcast Platform: With D. Ross Camidge, MD, PhD; and Rahul Gosain, MD, MBA

November 20th 2024

Drs Camidge and Gosain discuss how Dr Gosain harnessed social media to create a podcast with practice updates for up-and-coming oncology professionals.

Clinical Oncology Bridges Gaps Between Medical Oncology, Radiation Oncology, and Clinical Research: With D. Ross Camidge, MD, PhD; and Duncan McLaren, MBBS, BSc, FRCR, FRCP

November 13th 2024

Drs Camidge and McLaren discuss Dr McLaren’s journey to medical school and his experience as a clinical oncologist with expertise across disciplines.

Patient Prioritization Is the Foundation for a Successful Neurologic Oncology Career: With D. Ross Camidge, MD, PhD; and Douglas Ney, MD

October 23rd 2024

Drs Camidge and Ney discuss Dr Ney’s journey to becoming a neurologic oncologist and his experience as a physician with Tourette syndrome.

FDA Involvement in Dose Optimization Through Project Optimus Drives a Patient-Focused Oncology Pharmacology Career: With D. Ross Camidge, MD, PhD; and Jeanne Fourie Zirkelbach, PhD

October 9th 2024

Drs Camidge and Zirkelbach discuss Zirkelbach's first pharmacokinetics forays and her involvement with reforming dose optimization in drug development.

Camidge and Wilfong on Making A Difference Through a Career in Continuing Medical Education

September 12th 2024

D. Ross Camidge, MD, PhD, and Kadrin Wilfong, MD discuss Wilfong's passion for continuing medical education (CME) and how CME events and resources can make a difference in the care of patients with cancer.

Camidge and Kahl Reflect on the Impact of Oncology Journalism

July 22nd 2024

Camidge and Kahl reflect on the steps in Kahl’s communications career that paved the way for her to become a leader in the medical journalism field.

Camidge and White on Crucial Aspects of Patient-Focused Oncology Communication

July 4th 2024

Camidge and White discuss the intersections between White’s head and neck cancer diagnosis and radiation oncology communications career.

Camidge and Cooper on Finding Purpose and Embracing Nuance in Hospital Chaplaincy

June 13th 2024

Camidge and Cooper discuss Cooper’s career as a hospital chaplain, the focus of her writing, and the importance of meeting patients where they are.

Key Takeaways in HER2-Mutated NSCLC

May 29th 2024

The panel concludes the discussion with key takeaways on the evolving treatment landscape in HER2 non–small cell lung cancer.

Treatment Considerations in HER2-Mutated NSCLC

May 29th 2024

Experts on HER2 NSCLC provide clinical insights on selecting between antibody-drug conjugates and TKIs, treatment sequencing, and the role of chemoimmunotherapy.